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RNA polymerase III activity is increased in some cancers.
Effects of its inhibition in mammals are not known. We show
that a mutation in the Pol III subunit Polr3b in the murine
intestine results in crypt failure and increased mortality. Our
conditional model will allow for the study of Polr3b function
in all cell types in the mouse.
BACKGROUND & AIMS: The continuously self-renewing
mammalian intestinal epithelium, with high cellular turnover,
depends on adequate protein synthesis for its proliferative
capacity. RNA polymerase III activity is related closely to cellular
growth and proliferation. Here, we studied the role of Polr3b, a
large RNA polymerase III subunit, in the mammalian intestinal
epithelium.
METHODS: We derived mice with an intestinal epithelium-
speciﬁc hypomorphic mutation of the Polr3b gene, using
VillinCre-mediated gene ablation. Phenotypic consequences of
the Polr3b mutation on the intestinal epithelium in mice were
assessed using histologic and molecular methodologies,
including genetic lineage tracing.
RESULTS: The Polr3b mutation severely reduced survival and
growth in mice during the ﬁrst postnatal week, the period when
the expansion of the intestinal epithelium, and thus the
requirement for protein synthesis, are highest. The neonatal
intestinal epithelium of Polr3bloxP/loxP;VillinCre mice was char-
acterized by areas with reduced proliferation, abnormal
epithelial architecture, loss of Wnt signaling, and a dramatic
increase in apoptotic cells in crypts. Genetic lineage tracing
using Polr3bLoxP/LoxP;Rosa26-lox-stop-lox-YFP;VillinCre mice
showed that in surviving mutant mice, Polr3b-deﬁcient dying
crypts were replaced progressively by Cre-escaper cells that
had retained wild-type Polr3b function. In addition, enteroids
cultured from Polr3bloxP/loxP;VillinCre mice showed reduced
proliferative activity and increased apoptosis.
CONCLUSIONS: We provide evidence for an essential role of the
RNA polymerase III subunit Polr3b in orchestrating the main-
tenance of the intestinal crypt during early postnatal develop-
ment in mice. (Cell Mol Gastroenterol Hepatol 2016;2:783–795;
http://dx.doi.org/10.1016/j.jcmgh.2016.08.003)
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Enteroids.he small intestinal epithelium is the fastestTself-renewing tissue in mammals, and thus highly
dependent on adequate protein synthesis for proliferation,
especially during early postnatal development, when the
expansion of the epithelial layer takes place. In neonatal mice,
intervillus regions of the intestinal epithelium reorganize to
give rise to highly proliferative crypt structures, which
increase in number and size during this transition from
neonatal to adult function.1
The RNA polymerase III (Pol III) complex transcribes
small noncoding RNAs (sncRNAs), such as transfer RNAs
(tRNAs), U6 snRNAs, and 5S ribosomal RNAs (rRNAs),2
which all are involved directly or indirectly in protein syn-
thesis. Studies in Saccharomyces cerivisiae have shown many
factors and mechanisms that regulate Pol III transcription.3
These studies clearly show that high Pol III activity is
required during conditions of rapid growth, whereas
reduction in Pol III activity is observed during nutrient
deprivation.4 Although the Pol III complex is highly
conserved from yeast to human beings, unlike in yeast, Pol
III targets are repressed differentially in response to
nutrient deprivation in human ﬁbroblasts, indicating that
mechanisms of transcriptional regulation of Pol III genes are
more complex in mammals.5
Although Pol III traditionally has been regarded as
functioning in a housekeeping capacity, studies in meta-
zoans have shown sophisticated mechanisms of transcrip-
tional regulation of Pol III targets, including cell
type–speciﬁc transcription of different tRNA genes.6 In
mammalian cells, numerous studies have pointed to Pol III
dysregulation as playing a role in oncogenic trans-
formation.6,7 In support of this ﬁnding, overexpression of
Pol III transcripts has been described in multiple cancers
784 Kieckhaefer et al Cellular and Molecular Gastroenterology and Hepatology Vol. 2, No. 6and in transformed cell lines.8–11 The proto-oncogene pro-
teins mechanistic target of rapamycin complex 1 (mTORC1),
myelocytomatosis oncogene (MYC), p53, and retinoblas-
toma all directly regulate transcription by Pol III in human
cells.12–15 Thus, comprehending the function and regulation
of Pol III is vital to the understanding of tissue growth in
health and disease.
Despite the importance of Pol III, little is known about its
requirement during development. In zebraﬁsh, a large-scale
mutagenesis screen recovered a mutation, termed slim jim
(slj), that causes an in-frame deletion in the gene encoding the
second-largest Pol III subunit, Polr3b.16 The mutation has a
profound effect on the proliferation and growth of intestinal
epithelial progenitor cells, consistent with a high demand for
protein synthesis in the rapidly proliferating intestinal
epithelium.
The continuously self-renewing mammalian intestinal
epithelium, with high cellular turnover, provides an attrac-
tive system to study the role of the Pol III complex in
mammalian cell proliferation. Based on data from previous
studies in the slj zebraﬁsh, we hypothesized that Polr3b
might play an important role in the growth and develop-
ment of the mammalian gut. To study this hypothesis, we
generated a conditional hypomorphic mutation of Polr3b
speciﬁcally in the mouse intestinal epithelium.
Here, we show that the disruption of the Pol III complex
in the intestinal epithelium by Polr3b mutation leads to a
severe developmental phenotype, mainly characterized by
increased mortality, accompanied by reduced proliferative
and differentiation capacity, impaired crypt maturation, and
reduced Wnt signaling in the intestinal epithelium. In
summary, our data show the important role of RNA poly-
merase III in regulating the establishment of the intestinal
epithelium in mammals.Methods
Derivation of Polr3bloxP/loxP;VillinCre Mice
The Polr3b conditional mutant allele was derived in
mouse embryonic stem cells via homologous recombination
using the targeting construct shown in Figure 1A. LoxP
sites ﬂanking exon 10 allow for ablation of exon 10 in
Polr3bloxP/loxP upon Cre activation. The neomycin cassette
was excised by crossing the F1 offspring with Flp1 deleter
mice.17 To ablate Polr3b conditionally in the intestinal
epithelium, Polr3bloxP/þ mice were crossed with VillinCre
mice, kindly provided to us by Deborah Gumucio,18 to obtain
Polr3bloxP/þ;VillinCre and Polr3bloxP/loxP;VillinCre mice. Gen-
otyping was performed by polymerase chain reaction (PCR)
analysis of genomic tail DNA (data not shown). The following
primers were used to detect the Polr3bwild-type andmutant
allele, yielding a 222-bp product and a 519 bp product,
respectively: 5’-AGCCTCATTTCTTCGTGGTGA-3’ and
5’-TGGCCTAGGAAGGGAAGAAAA-3’. Polr3bloxP/þ;VillinCre
and Polr3bloxP/loxP mice show no abnormalities and are viable
and fertile. The Cre transgene was detected using: 5’-
GCGGCATGGTGCAAGTTGAAT-3’ and 5’-CGTTCACCGGCAT-
CAACGTTT-3’ primers (product size, 232 bp). To perform
lineage tracing experiments, Polr3bloxP/þ;VillinCre andPolr3bloxP/loxP mice were crossed with R26-stop-EYFP mice
(B6.129X1-Gt[ROSA]26Sortm1(EYFP)Cos/J) obtained from The
Jackson Laboratory (Bar Harbor, ME). All procedures
involving mice were conducted in accordance with approved
Institutional Animal Care and Use Committee protocols.Laser Capture Microdissection and Subsequent
PCR Analysis of Wild-Type and Mutant Alleles
Parafﬁn-ﬁxed intestinal tissue was sectioned (5 mm) on
nuclease and nucleic acid–free frame slides for laser
microdissection (Part #: FS-LMD-M-50r; MicroDissect
GmbH; Herborn, Germany). Unstained and dehydrated
tissue was air-dried and processed immediately for laser
capture microdissection. Crypt regions were dissected from
Polr3bloxP/loxP;VillinCre mice and their wild-type littermates
into PCR sample tubes for laser microdissection (ASSEE,
ST-LMD-M-500), subsequent overnight proteinase K diges-
tion, and PCR analysis for the presence of the wild-type and
mutant Polr3b allele using the following primers: 5’-GAC-
GAATTCCTGCAGCCCAAT-3’ (Polr3bF) with 5’-CCCTGGAAT-
GAACAGGGGAAA-3’ (Polr3bR1), which yields a wild-type
product of 930 bp and a mutant product of 337 bp. Addi-
tional PCR analysis was performed using the same Polr3bF
primer and the Polr3bR2 primer: 5’-GTGGCCGCTTACTGA-
GATGAA-3’ to detect only the wild-type product of 530 bp.
Antibodies
The following antibodies were used for immunoﬂuo-
rescent or immunohistochemical analysis: rabbit anti-Ki67
(VP-K451, 1:1000; Vector Laboratories; Burlingame, CA),
rabbit anti-lysozyme (A0099, 1:1000; Dako; Glostrup
Municipality, Denmark), mouse anti–E-cadherin (610181,
1:500; BD Transduction Laboratories; San Jose, CA), chicken
anti-green ﬂuorescent protein (GFP) for the detection of
enhanced yellow ﬂuorescent protein (EYFP) (GFP-1020,
1:2000; Aves Labs; Tigard, OR), rabbit anti-cyclin D1 (CRM
307, 1:100; Biocare Medical; Concord, CA), rabbit anti-
cleaved caspase-3 (9661, 1:200; Cell Signaling Technology;
Danvers, MA), mouse anti–b-catenin (610153, 1:200; BD
Biosciences, San Jose, CA), and rabbit anti–mucin 2 (sc-
15334, 1:1000; Santa Cruz Biotechnology; Dallas, TX). Cy2-
and Cy3-conjugated ﬂuorescent secondary antibodies were
purchased from The Jackson Laboratory and used at a 1:200
dilution. Biotinylated secondary antibodies for immunohis-
tochemical assays (Vector Laboratories) were used at a
1:200 dilution along with the ABC detection system
(PK-6100; Vector Laboratories).Terminal Deoxynucleotidyl Transferase–Mediated
Deoxyuridine Triphosphate Nick-End
Labeling Assay
To detect apoptotic cells in the intestinal epithelium,
we performed the terminal deoxynucleotidyl
transferase–mediated deoxyuridine triphosphate nick-end
labeling (TUNEL) assay using an in situ cell death detection
kit according to the manufacturer’s instructions (Roche
Applied Science; Penzburg, Germany). Cell death was
Figure 1. Intestine-speciﬁc, conditional hypomorphic mutation of the Polr3b gene, encoding a large subunit of RNA
polymerase III, causes reduced survival, delayed growth, and decreased intestinal epithelial transcription of snRNAs.
(A) Targeting strategy used for conditional ablation of exon 10 of the Polr3b gene. After germ-line transmission, the
FRT-ﬂanked neomycin resistance gene (PGK-Neo cassette) was excised by crossing to Flp deleter mice (Flp). Polr3bloxP/loxP;
VillinCre mice were derived by intercrossing Polr3bLoxP/þ with VillinCre mice. (B) Kaplan–Meier survival curve of control and
mutant mice during the ﬁrst 8 postnatal days, showing a signiﬁcantly lower survival rate in Polr3b-mutant mice compared with
littermate controls (log-rank [Mantel–Cox] and Gehan–Breslow–Wilcoxon test; P < .0001, N ¼ 12–28). (C) Signiﬁcantly reduced
body weight during the preweaning period in Polr3b-mutant mice (means ± SEM; *P < .05; N ¼ 3–47). During weaning, when
the regenerative response was observed, Polr3b-mutant mice started to catch up in body weight with their littermate controls.
(D) Polr3b-mutant mice (right) are visibly smaller than their control littermates (left), on postnatal day 3 (P3). (E) P1 control and
mutant stomach, large intestine, and colon. (F) Real-time qPCR analysis of expression of tRNA-Arg, tRNA-Asn, tRNA-Cys,
tRNA-His, 5S rRNA, and U6 snRNA in the jejunum of E18.5 control (N ¼ 7) and mutant (N ¼ 10) mice (means ± SEM;
*P ¼ .0496, Student t test; **P ¼ .002, Mann–Whitney test). Data were normalized to the means of snoRNA 202 and
snoRNA 234.
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per crypt in jejunal sections from P21 mice (control, N ¼ 4;
mutant, N ¼ 4). An average of 20 crypts were counted per
animal.
Quantitative PCR Analysis
For the analysis of stem cell markers, total RNA
was extracted from the jejunal tissue using the TRIzol
reagent method (15596-026; Invitrogen, Carlsbad, CA).
Complementary DNA (cDNA) synthesis and quantitative
PCR analysis were performed as described.19 Gene
expression was normalized to messenger RNA levels of
glyceraldehyde-3-phosphate dehydrogenase. Primer se-
quences used for the quantitative PCR analysis have been
reported previously.20–23
To measure the expression of Pol III targets, total RNA
was extracted from the jejunal tissue at embryonic day 18.5
(E18.5) mice using the mirVana miRNA Isolation Kit
(AM1560; Life Technologies, Carlsbad, CA). cDNA synthesis
and quantitative PCR analysis were performed using custom
TaqMan Small RNA Assays (4440418; Life Technologies) for
tRNA-Arg, tRNA-Asn, tRNA-Cys, tRNA-His, and 5S rRNA.
TaqMan MicroRNA Assays (4427975; Life Technologies)
were used for cDNA synthesis and quantitative PCR analysis
of U6 snRNA, small nucleolar (snoRNA) 202, and snoRNA
234. Gene expression was normalized to the mean level
of snoRNA 202 and snoRNA 234. Primer sequences are
available on request.Intestinal Crypt/Enteroid Culture
Small intestine was harvested from P1 Polr3b-mutant and
control mice. After a 30-minute EDTA (5 mmol/L) incubation,
the intestinal crypts were ﬁltered through a 70-mm cell
strainer. Crypts were plated suspended in Matrigel (356231;
BDBiosciences) and cultured in advancedDulbecco’smodiﬁed
Eagle medium/F-12 (12634010; Thermo Fisher Scientiﬁc,
Waltham,MA) containing theWnt agonist R-spondin1 (Protein
Expression Facility, The Wistar Institute, Philadelphia, PA),
murine epidermal growth factor (PMG8043; Life Technolo-
gies), murine Noggin (250-38; Peprotech, Rocky Hill, NJ), and
the Gsk3 inhibitor CHIR99021 (1677-5; BioVision, Milpitas,
CA) as reported previously.24,25 On days 2, 4, and 6, pooled
enteroids were genotyped by quantitative PCR (qPCR) for the
presence of the deleted allele using primers Polr3bF and
Polr3bR1, as described earlier, and the undeleted allele using
primers Polr3bF2: 5’-GCTTGATATCGAATTCCGAAG-3’ and
Polr3bR: 5’-CCTCTCTGGAACTCCAACCAA-3’. The quantity of
genomic DNA present in qPCR reactions was normalized to
genomic b-actin. In addition, proliferation and apoptosis were
assessed in developing enteroids by immunoﬂuorescent
analysis of Ki67 and cleaved caspase-3, respectively, as
described earlier.
Statistical Analysis
Values represent means ± standard error of the mean for
the indicated number of mice per group. Differences
between groups were determined using an unpairedStudent t test (2-tailed), with a signiﬁcance cut-off P value of
less than .05, unless indicated otherwise. The percentages of
the undeleted allele quantiﬁed in enteroids by qPCR at 3
different time points (2, 4, and 6 days in culture) were
compared using the Kruskal–Wallis test, followed by the
Dunn multiple comparison test. Analysis was performed
with GraphPad Prism 5 software (GraphPad Software, Inc,
La Jolla, CA).
Results
Polr3bloxP/loxP;VillinCre Mice Have Reduced
Survival and Growth
To study the contribution of the RNA polymerase III
complex in the intestinal epithelium of mice, we derived
mice with a conditional hypomorphic mutation of the Polr3b
gene, which encodes Polr3b, a major subunit of Pol III
(Figure 1A). The Polr3b mutation resulted in major mor-
tality, with only 60% of Polr3bloxP/loxP;VillinCre mice (here-
after referred to as Polr3b-mutants) surviving the ﬁrst
postnatal week (Figure 1B). Surviving mutant mice lagged
behind their control littermates in growth until the third
postnatal week (Figure 1B and C). Though there was no
difference in intestinal length when normalized to body
weight (data not shown), early postnatal mutant mice were
signiﬁcantly smaller and had shorter intestines than their
littermate controls (Figure 1C–E). As expected, before birth
(E18.5), the intestinal tissue of Polr3bloxP/loxP;
VillinCre mice already showed a signiﬁcant reduction in the
expression levels of the 5S and U6 RNAs, key components of
the ribosome and splicing machinery, respectively,
compared with control (Polr3bloxP/loxP) mice (Figure 1F).
Milk was present in the stomach of Polr3b-mutant mice
from the ﬁrst postnatal day until 3 weeks of age (data not
shown), suggesting that Polr3b-mutant mice fed normally.
Newborn Polr3b-Mutant Mice Show Reduced
Proliferation and Impaired Crypt Development
Given the slower growth rate of mutant animals and
the signiﬁcant reduction in the mutant epithelium of RNAs
required for translation, we hypothesized that there were
defects in proliferation in the mutant intestine. Therefore,
we performed immunostaining for Ki67, a protein that
marks the transit-amplifying cells of the intestinal
epithelium. Polr3bloxP/loxP;VillinCre intestine had clear
regions lacking Ki67-positive cells at P7, P14, and P21
(Figure 2D, F, and H), which was indicative of reduced
proliferative capacity in the intestinal epithelium of young
Polr3b-mutant mice. In addition, P14 mutant intestinal
epithelial areas with reduced numbers of Ki67-positive
cells were lacking fully developed crypts, which normally
are present by this stage in control mice (Figure 2E vs F).
In regions lacking Ki67, crypts still were not present by
P21 in Polr3b-mutant mice (Figure 2H). At P21, the areas
with reduced numbers of Ki67-positive cells were sur-
rounded by hyperproliferative regions that had increased
numbers of Ki67-positive cells (Figure 2H), suggesting
regenerative mechanisms were activated in regions with
surviving crypts.
Figure 2. Proliferation is
reduced in the small in-
testine of neonatal
Polr3bloxP/loxP;VillinCre,
followed by sporadic hy-
perplasia and enhanced
proliferative activity dur-
ing weaning. Ki67 immu-
nohistochemistry of
control and Polr3b-mutant
mice at (A and B) P1, (C
and D) P7, (E and F) P14,
and (G and H) P21. At all
stages, Polr3b-mutant
mice show jejunal regions
lacking Ki67-positive cells.
At P21, the epithelium of
Polr3b-mutant mice shows
hyperproliferative regions
with expanded crypts.
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Figure 3. Hyperplastic regions of the Polr3b-mutant intestinal epithelium at P21 contain wild-type Cre-escaper cells
with the undeleted Polr3b allele. (A) H&E staining of the intestinal epithelium showing the morphology of the jejunal
epithelium of control and mutant mice at P1 (magniﬁcation, 20), P7 (magniﬁcation, 10), P21 (magniﬁcation, 20), and in
adults (age, 2–3 mo) (magniﬁcation, 20). Areas with expanded mesenchyme, villus branching, and lack of developing crypts
are present in P7 Polr3b-mutant epithelium (yellow box). At P21, hyperplastic areas are clearly visible in mutant mice (yellow
box). In adults, the intestinal epithelium of Polr3b-mutant mice shows improved morphology; however, areas with villus
branching still are detected (yellow box). (B) Representative pictures before and after laser capture microdissection (LCM) of
crypts dissected from 3-week-old control mice and hyperplastic regions from mutant mice. (C) Scheme of primer design and
PCR product size for ampliﬁcation using different primer sets for LCM–PCR analysis. Primers F and R1 were designed sur-
rounding the loxP sites ﬂanking exon 10 of the Polr3b gene, resulting in the ampliﬁcation of the longer, undeleted Polr3b PCR
product (1018 bp) or the shorter, mutant Polr3b gene PCR product (337 bp). An additional reverse primer (R2) was designed
within the loxP-ﬂanked region of the Polr3b gene, which when used with the forward (F) primer, results in the ampliﬁcation of
the undeleted Pol3b PCR product only (530 bp). (D) PCR results for LCM-dissected regions from control crypts (control) and
Polr3b-mutant crypts from hyperplastic regions (mutant HR), showing the presence of the undeleted Polr3b allele in control
crypts, and both deleted as well as undeleted alleles in Polr3b-mutant crypts from hyperplastic regions using both primer
combinations (F þ R1 and F þ R2).
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Epithelial Architecture
Morphologically, the intestinal epithelium of young
Polr3b-mutant mice was affected severely, showing
abnormal crypt and villus architecture (Figure 3A). At
earlier developmental stages (E17.5 and P1), no obvious
morphologic defects were detected in mutants (data notshown and Figure 3A, respectively). By P7, epithelial
defects were present in all regions of the mutant small
intestine and were characterized by an expanded mesen-
chymal layer, lack of developing crypts, and branched
villus-like structures (Figure 3A). At weaning (P21), the
intestinal epithelium of Polr3b-mutant mice continued to
show similar morphologic changes to those seen at P7. In
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matic hyperplasia (Figure 3A). In contrast to younger an-
imals, a large fraction of the epithelium of adult mutant
mice had normal morphology. However, regions of disor-
ganized epithelium with branched villi and crypt expan-
sion still were detected in adult Polr3b-mutants
(Figure 3A).Undeleted Cre Escaper Cells Proliferate
in Hyperplastic Regions of Mutant
Intestinal Epithelium
The regenerative response, indicated by the presence of
hyperplastic regions and increased proliferation of the
intestinal epithelium seen in P21 Polr3b-mutant mice
(Figure 3A), could be explained by stem cells that had
escaped Cre-mediated gene ablation. Such incomplete gene
deletion has been reported previously in other studies using
the Cre system in the mouse intestinal epithelium.24
Epithelial stem and transit-amplifying cells that escape
Cre-mediated mutation, and thus have retained normal
Polr3b function, would be expected to have a signiﬁcant
growth advantage over mutant cells.
To assess the presence of undeleted Cre escaper cells in
Polr3b-mutant mice in vivo, we performed laser capture
microdissection to dissect crypts from control mice and
from hyperplastic regions in Polr3b-mutant mice
(Figure 3B). Subsequently, we PCR-ampliﬁed the region of
the Polr3b locus encoding the loxP sites to detect undeleted
and deleted Polr3b-mutant alleles. Indeed, the presence of
the undeleted Polr3b allele in the hyperplastic areas of the
intestinal epithelium of Polr3bloxP/loxP;VillinCre mice was
conﬁrmed by PCR assay using 2 sets of primers (Figure 3C
and D). These data indicate the presence of wild-type
escaper cells with the undeleted allele in the
Polr3b-mutant intestinal epithelium, which likely were
driving the regenerative response described earlier.
To determine the contribution of apoptosis to the loss of
developing crypts in the Pol3b-mutant intestinal epithelium,
we performed TUNEL assays on P3 (Figure 4A and B) and
P21 (Figure 4C and D) intestines. Because of the mosaicism
in Cre activity observed in the mutant mouse, to distinguish
between escaper regions and recombined (mutant) regions
in the epithelium, we crossed our Polr3bloxP/loxP;VillinCre
mice with R26-stop-EYFP mice. Thus, in regions where Cre
was efﬁcient, the epithelium expressed EYFP as detected by
immunostaining (Figure 4A and B). In the control epithelium
at P3, no apoptotic cells were detected (Figure 4A), while in
the mutant epithelium, apoptotic cells were present in
EYFP-positive crypts, but not in EYFP-negative cells
(Figure 4B). At P21, apoptotic cells were detected in the
mesenchyme, but not the epithelium, of control mice
(Figure 4C), but apoptotic crypts with TUNEL-positive cells
were detected in the mutant epithelium (Figure 4D). A
blinded count of the TUNEL-positive cells per crypt in P21
intestine showed that there were signiﬁcantly more
apoptotic cells in the mutant intestinal epithelium than in
the control epithelium (control, 0.2 TUNEL-positivecells/crypt, N ¼ 4; mutant, 1.2 TUNEL-positive cells/crypt,
N ¼ 4; P ¼ .0012) (Figure 4E).Undeleted Cre Escaper Cell Populations Expand
Over Time In Vitro
We hypothesized that if stem cells had escaped Cre-
mediated gene ablation, a progressive increase would
result in the proportion of cells carrying the undeleted allele
as the epithelium expands during development. Therefore,
to directly measure changes in the abundance of epithelial
cells expressing undeleted Polr3bloxP/loxP over time, and
without the potential contamination of mesenchymal cells,
we harvested epithelial tissue from newborn control and
Polr3b-mutant mice and cultured it in vitro into enteroids
(Figure 5; experimental scheme shown in Figure 5A).
Indeed, the fraction of the undeleted allele increased
signiﬁcantly between days 2 and 6 in culture (P < .05),
initially comprising 18% on day 2 in culture, and increasing
to 46% on day 6, as shown by qPCR-based quantiﬁcation of
the undeleted allele shown in Figure 5B.
To determine whether the defects in proliferation
observed in vivo in mutant epithelium persisted when the
epithelium was cultured in vitro, we immunostained enter-
oids for Ki67. Although all of the control enteroids formed
Ki67-positive crypt-like domains (Figure 5C), indicating the
presence of stem cells and transit-amplifying cells, mutant
enteroids developed into 2 distinctly different structures:
enteroids that resembled controls (Figure 5D), and enteroids
that formed dilated, cyst-like structures (Figure 5E).
Although the cyst-like enteroids expressed Ki67, they failed
to form crypt-like domains.
To assess cell death in vitro, after 6 days in culture we
stained enteroids for activated caspase-3 (Figure 5F and G).
Control enteroids showed no apoptotic cells within the
epithelial layer, caspase-3 staining was present only in dead
cells shed into the enteroid lumen (Figure 5F). In contrast, as
we also observed by TUNEL staining in vivo, Polr3b-deﬁcient
enteroids showed a high frequency of apoptotic cells within
the enteroid epithelium itself (Figure 5G). This is consistent
with the hypothesis that the intestinal epithelium is being
repopulated by cells expressing the undeleted allele in
response to the increased rate of apoptosis in mutant cells.Over Time, Polr3bloxP/loxP;VillinCre Crypts Are
Replaced by Highly Proliferative Cre-Escaper
Cells In Vivo
To conﬁrm that the regions of disrupted proliferation
observed in Polr3b-mutant intestine were in tissue where
Cre was active, while regions of hyperproliferation were
derived from Cre-escapers, we performed Ki67 immuno-
staining on epithelia from Rosa26-lox-stop-lox-EYFP;VillinCre
(control) and Polr3bLoxP/LoxP;Rosa26-lox-stop-lox-EYFP;Vil-
linCre (mutant) P3 mice (described earlier). As expected,
controls uniformly expressed Ki67 at the base of each
intervillus region (Figure 6C). In contrast, in regions of
mutant epithelium where Cre was active, as indicated by
Figure 4. The Polr3b mutation is associated with crypt cell death. Apoptotic cells (red) in the crypts were detected by
performing the TUNEL assay on intestinal epithelial tissue at (A and B) P3 and (C and D) P21 (weaning). (A and B) Green
staining represents EYFP in Polr3bLoxP/LoxP; Rosa26-lox-stop-lox-EYFP;VillinCre mutant or Rosa26-lox-stop-lox-EYFP;Villin-
Cre control mice and is visible only in Cre-expressing tissue. Red, TUNEL; white, E-cadherin; and blue, 40,6-diamidino-2-
phenylindole. For increased clarity, the inset in panel B, which is a 3 enlargement of the dying crypt indicated by the
yellow arrow, shows only EYFP and TUNEL staining. (C and D) Green, E-cadherin; red, TUNEL; and blue, DAPI. Even during
weaning (P21), (C) TUNEL-positive crypts were absent from the control epithelium, (D) but still present in the intestinal
epithelium of mutant animals. The inset in D is a 2 enlargement of the dying crypt indicated by the yellow arrow. (A and C) No
TUNEL-positive cells were detected in crypts of control mice, although apoptotic cells were detected in the mesenchyme. (B
and D) Crypt epithelial cells positive for TUNEL staining were present in Polr3b-mutant intestinal epithelium in neonates and
during weaning. (B) TUNEL-positive epithelial cells were present only in the tissue where Cre was active in mutant animals. (E)
Apoptosis was increased signiﬁcantly in mutant epithelium at P21. Cell death was quantiﬁed by counting the number of
TUNEL-positive cells per crypt in jejunal sections from P21 mice (control, N ¼ 4; mutant, N ¼ 4; *P < .002, Student t test).
790 Kieckhaefer et al Cellular and Molecular Gastroenterology and Hepatology Vol. 2, No. 6EYFP staining, very little Ki67 was detected, whereas in
EYFP-negative Cre-escaper regions, intervillus regions were
expanded and contained dense clusters of Ki67-positive
cells (Figure 6D, yellow bracket).The nonproliferative, Ki67-negative regions interspersed
with hyperproliferative crypts observed in the Polr3b-mutant
small intestine resemble small intestinal epithelium that
regenerates after exposure to ionizing radiation. The
Figure 5. Increased cell
death was accompanied
by expansion of Cre-
escaper cells in the
Polr3b mutant epithelium
in vitro. (A) Scheme for the
culture and harvesting of
P1 intestinal enteroids. (B)
Quantiﬁcation of the
undeleted Polr3b exon 10
in genomic DNA from
enteroids after 2, 4, and 6
days in culture, as shown
in panel E (control, N ¼ 5;
mutants, N ¼ 6; error bars
indicate SEM; *P < .05,
Kruskal–Wallis test of mu-
tants followed by the Dunn
multiple comparison test).
(C–E) Ki67 staining of
enteroids from P1 gut after
4 days in culture. Mutant
enteroids developed into 2
distinctly different struc-
tures: (D) enteroids with
Ki67 expression at the tips
of crypt-like buds, (C)
resembling controls, and
(E) dilated, cyst-like struc-
tures with patches of Ki67
expression surrounded by
ﬂattened Ki67-negative
cells. (F and G) Cleaved
caspase 3 (CASP3; red)
staining of enteroids from
P1 gut after 6 days in cul-
ture (blue, 40,6-diamidino-
2-phenylindole). Increased
cell death was detected in
Polr3b-mutant enteroids
compared with controls.
(F) In control enteroids, cell
death was detected only in
cells shed into the lumen,
whereas (G) in mutant
enteroids, cell death also
was seen in peripheral
cells that formed the
actual enteroid (yellow ar-
rows). Magniﬁcation, 40.
Scale bar: 50 mmol/L.
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792 Kieckhaefer et al Cellular and Molecular Gastroenterology and Hepatology Vol. 2, No. 6regenerative response in injured intestine is driven by Wnt
signaling.26 Indeed, even in irradiated crypts in which Lgr5þ
stem cells have been ablated, constitutive activation of Wnt by
ablation of Apc is sufﬁcient to drive crypt hyperplasia.27Therefore, to determine whether Wnt pathway activation
contributed to proliferation in escaper regions of Polr3b-
deﬁcient gut, we performed immunostaining for the Wnt
target cyclin D1.
November 2016 Polr3b in the Intestinal Epithelium 793At P3, immunohistochemical staining showed that
in controls, cyclin D1 was expressed uniformly in the
intervillus regions (Figure 6E), whereas mutant regions
(EYFP-positive regions) of the Polr3b-mutant epithelium
lacked cyclin D1–positive cells (Figure 6F). In contrast,
EYFP-negative regions of the P3 Polr3b-mutant epithelium
(highlighted by a yellow bracket), showed dense clusters of
cyclin D1–positive cells (Figure 6F). Lack of active Wnt
signaling in the Polr3b-deﬁcient small intestine was
conﬁrmed by staining for b-catenin. As shown in Figure 6G,
in control tissue, intervillus regions show strong cyto-
plasmic and nuclear b-catenin staining, indicative of Wnt
pathway activation. In striking contrast, most of the P3
Polr3b-mutant epithelium is b-catenin negative, with the
exception of an area of regenerative epithelium bracketed in
yellow (Figure 6H).Discussion
Previous studies in yeast and zebraﬁsh have shown the
importance of the RNA Pol III complex in cell growth and
tissue development. More speciﬁcally, the zebraﬁsh mutant
slj, with a mutation in the second largest Pol III subunit
Polr3b, causes defects in digestive tract development.16
Here, we present a model to study the role of Pol III in
mammalian intestinal epithelial development and prolifer-
ation. We show that decreased activity of the Pol III complex
in the mouse intestinal epithelium leads to increased mor-
tality of Polr3b-mutant mice in the ﬁrst postnatal week.
Surviving Polr3b-mutant mice show reduced proliferation,
impaired crypt development, and loss of active Wnt
signaling. This initial phenotype is followed by a regenera-
tive response around weaning, which is driven by cells that
escape Cre-mediated mutation (Figure 7A). Because of the
diminished Pol III activity caused by the Polr3b mutation,
and resulting low levels of 5S rRNA and U6 snRNA, the high
demand for protein synthesis during early intestinal
epithelial tissue expansion cannot be met. These events
result in impaired crypt development and increased
apoptosis in crypts. These data show the important role of
Polr3b and the Pol III complex in the establishment of the
intestinal epithelium during early postnatal life in mammals
(Figure 7B). The conditional hypomorphic Polr3b-mutant
mice described earlier will allow a detailed investigationFigure 6. (See previous page). Hyperproliferative Cre-escap
lium. Rosa26-lox-stop-lox-YFP mice were crossed with Polr3b
are Polr3b mutant (YFP-positive), and which are Polr3b wi
E-cadherin; green, EYFP; and blue, 40,6-diamidino-2-phenylind
(B) Polr3bLoxP/LoxP; Rosa26-lox-stop-lox-YFP;VillinCre (mutant)
that is negative for YFP. (C and D) Red, Ki67; green, EYFP; an
escaper region (yellow bracket) of the mutant intestine have (
control intestine. (D) Almost no Ki67 was visible in Polr3b mutan
green, EYFP; and blue, 40,6-diamidino-2-phenylindole. (F) In Po
D1 is reduced in mutant tissue compared with the (E) control int
cyclin D1 staining (yellow bracket). (G and H) Brown, b-catenin
YFP;VillinCre (control) jejunum. (H) Polr3bLoxP/LoxP; Rosa26-lox
indicates a Cre-escaper region that has active Wnt signaling,of the contribution of RNA polymerase III in all tissue and
cell types for which a Cre line is available.
The epithelium of the small intestine is the most rapidly
self-renewing mammalian tissue, and thus it is required to
be capable of modulating protein synthesis in response to
environmental stress or during tissue expansion/growth.
During periods of starvation, the gut responds by decreasing
villus size, crypt size, and the rate of cell cycling.28 Protein
malnutrition alone also results in histologic abnormalities,
such as villi fused at the base accompanied by villus
blunting, or even the absence of villus architecture.29 The
Pol III complex plays an essential role in protein synthesis in
all eukaryotic cells.30 Therefore, sufﬁcient Pol III activity is
predicted to be essential for intestinal epithelial function
and survival.
The simplest explanation of the disrupted development
of the small intestine of Polr3b mutants is that the reduced
Pol III activity impairs cell proliferation because the high
metabolic demands of the epithelium cannot be met. Indeed,
the mutant intestine shows several similarities to both fas-
ted and protein-starved small intestines: a decrease in
cycling cells, abnormal branched villus architecture, and
increased apoptosis in epithelial cells.28–31 The Polr3b
mutant intestine thus mimics the malnourished state
because the levels of 5S rRNA and U6 snRNA, which are
required for protein synthesis, are decreased as a result of
low Pol III activity. Defects in protein production machinery
thus have a phenotype reminiscent of amino acid deﬁciency,
because in both cases the high demand for protein synthesis
during early intestinal epithelial tissue expansion cannot be
met.
Yeast and zebraﬁsh studies have suggested that the
structural effects of Polr3b mutations resulting in impaired
transcription by Pol III are caused by the destabilization of
the interaction between the Polr3b protein and another Pol
III subunit, Polr3k.16,32 The yeast homolog of Polr3k is
required for Pol III to efﬁciently perform multiple rounds of
transcription on the same gene, which determines the
overall output of the complex.33 Thus, the Polr3b mutation
in mice results in a reduction in the overall abundance of Pol
III transcripts, but without a complete loss of transcription
by Pol III, as also was evident by the reduction, but not
elimination, of Pol III transcripts in the mutant intestine we
documented in Figure 1.er cells repopulate the Polr3b-mutant intestinal epithe-
LoxP/LoxP;VillinCre mice to show which sections of the tissue
ld-type Cre-escaper cells (YFP-negative). (A and B) Red,
ole. (A) Rosa26-lox-stop-lox-YFP;VillinCre (control) jejunum.
jejunum. The yellow bracket indicates a Cre-escaper region
d blue, 40,6-diamidino-2-phenylindole. (D) Crypts in the Cre-
C) a higher density of Ki67-positive cells than crypts in the
t tissue outside the bracketed area. (E and F) Red, cyclin D1;
lr3b-mutant mice, expression of the Wnt target protein cyclin
estine, whereas escaper regions have dramatically increased
; red, nuclear fast red counterstain. (G) Rosa26-lox-stop-lox-
-stop-lox-YFP;VillinCre (mutant) jejunum. The yellow bracket
as indicated by nuclear b-catenin staining.
Figure 7. Summary of the effects of the hypomorphic
Polr3b mutation on the intestinal epithelium. (A) Shortly
after birth, large areas lacking proliferative capacity are
present in mutant mice (newborn [P3]). During weaning
(P21), regions with abnormal crypt architecture lacking
proliferative capacity still are present. By P21, hyperplastic
regions, which are initiated by the wild-type stem cells that
have escaped Cre recombination of the Polr3b gene, are
evident. These regions repopulate the intestinal epithelium,
resulting in normalization of epithelial morphology in Polr3b-
mutant intestinal epithelium in adults. (B) The mutation in
Polr3b leads to reduced Pol III activity, which causes
impaired transcription of small noncoding RNAs required for
translation, resulting in increased crypt cell death, decreased
proliferative activity, impaired crypt maturation, and altered
epithelial architecture in mutant tissue. The increased
death of mutant cells creates a selective advantage
for Cre-escaper cells in the intestinal epithelium of Polr3b-
mutant mice.
794 Kieckhaefer et al Cellular and Molecular Gastroenterology and Hepatology Vol. 2, No. 6Not surprisingly, rapidly dividing cancer cells have an
extremely high demand for protein synthesis, and tRNA
abundance is increased in many cancers such as multiple
myeloma and breast cancer.9,34 Multiple oncogenic (extra-
cellular signal-regulated kinase (ERK), TORC1, and MYC)
and tumor suppressor (p53, MAF1, retinoblastoma)pathways regulate RNA polymerase III activity and thus
tRNA abundance (reviewed by White2 and Grewal7). Given
the development of small-molecule inhibitors of RNA poly-
merase III, reducing tRNA abundance has been suggested as
a novel targeted approach for cancer therapy. Indeed, in a
recent report, Yee et al16 used the RNA polymerase III in-
hibitor ML-60218 developed by Wu et al35 in combination
with the histone deacetylase inhibitor suberoylanilide
hydroxamic acid to reduce proliferation in 2 human
pancreatic adenocarcinoma cell lines.36 As noted by the in-
vestigators, the safety of ML-60218 in human beings has not
yet been evaluated. Given the striking dependency of the
mammalian intestinal epithelium on normal rates of RNA
polymerase III we showed earlier, it is questionable if
globally acting, small-molecule inhibitors of this enzyme can
be developed into successful drugs to treat cancer.References
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